Matthew Robin


Member of the Board of Directors, year of first election: 2006
M. Eng. in Chemical Engineering, Imperial College, University of London/UK
Non-executive member

Professional background (main stages):

1987 - 1998  
Lonza Fine Chemicals, various functions in the USA and in Switzerland (last function: Business Director US Custom Manufacturing)
1998 - 2003
Various senior management functions (last function: Head Disetronic Injection Systems), Disetronic Holding AG, Burgdorf/BE
2003 - 2006
CEO, Ypsomed Holding AG, Burgdorf/BE
2007 - 2011
Divisional Head Liquid Handling & Robotics, Tecan Holding AG, Männedorf/ZH
Since 2011
CEO, ELSA/Mifroma, Estavayer-le-Lac/FR 

Other important activities and vested interests:

President of the Qids Future Foundation

Key knowledge and experience:

International and strategic management – longtime operational and strategic leadership experience in the medical device and other regulated international businesses.

Manufacturing, innovation and human resources – many years of experience as business director and CEO of large producing companies.

Matthew Robin
British and Swiss citizen, born in 1965

Board of Directors COLTENE Group

Name Function Since
Nick Huber Chairman of the Board of Directors 2005
Erwin Locher Member of the Board of Directors 2009
Jürgen Rauch Member of the Board of Directors 2016
Matthew Robin Member of the Board of Directors 2006
Dr. Astrid Waser Member of the Board of Directors 2017
Prof. Dr. Roland Weiger Member of the Board of Directors 2013
Dr. Allison Zwingenberger Member of the Board of Directors 2018